Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: Reduction of microcirculatory impairment and functional deficits in a rabbit model - Laboratory investigation

Journal of Neurosurgery

Volumn 109, Issue 6, 2008, Pages 1155-1164

  Murphy, Amanda M ^a,b,c   Xenocostas, Anargyros ^c   Pakkiri, Pria ^b   Lee, Ting Yim ^a,b,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cerebral blood flow; Computed tomography; Erythropoietin; Rabbit; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; ERYTHROPOIETIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG MEGADOSE; EXPERIMENTAL RABBIT; HEMATOCRIT; HEMODYNAMICS; LOW DRUG DOSE; MALE; MICROANGIOPATHY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; SHAM PROCEDURE; SUBARACHNOID HEMORRHAGE; ANGIOGRAPHY; ANIMAL; BLOOD FLOW; CEREBELLUM; DOSE RESPONSE; DRUG EFFECT; MICROCIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RABBIT; VASCULARIZATION;

ANGIOGRAPHY; ANIMALS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; HEMATOCRIT; MALE; MICROCIRCULATION; MODELS, ANIMAL; RABBITS; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW; SUBARACHNOID HEMORRHAGE;

EID: 58149379230     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/JNS.2008.109.12.1155     Document Type: Article

References (49)

1. Adams HP Jr, Kassell NF, Torner JC, Haley EC Jr: Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the cooperative aneurysm study. Neurology 37:1586-1591, 1987
2. Asano T: Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions. Crit Rev Neurosurg 9:303-318, 1999
3. Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, et al: Erythropoietin regulates endothelial progenitor cells. Blood 103:921-926, 2004 (Pubitemid 38129551)
4. Baker KF, Zervas NT, Pile-Spellman J, Vacanti FX, Miller D: Angiographic evidence of basilar artery constriction in the rabbit: a new model of vasospasm. Surg Neurol 27:107-112, 1987 (Pubitemid 17229385)
5. Buemi M, Grasso G, Corica F, Calapai G, Salpietro FM, Casuscelli T, et al: In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur J Pharmacol 392:31-34, 2000 (Pubitemid 30169029)
6. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY: Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 20:63-73, 1999 (Pubitemid 30417673)
7. Chong ZZ, Kang JQ, Maiese K: Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J Cereb Blood Flow Metab 22:503-514, 2002
8. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, et al: Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495-505, 2002 (Pubitemid 36337492)
9. Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, et al: Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A 100:6741-6746, 2003 (Pubitemid 36666650)
10. Fainardi E, Tagliaferri MF, Compagnone C, Tanfani A, Cocciolo F, Battaglia R, et al: Regional cerebral blood flow levels as measured by xenon-CT in vascular territorial low-density areas after subarachnoid hemorrhage are not always ischemic. Neuroradiology 48:685-690, 2006 (Pubitemid 44355780)
11. Frykholm P, Andersson JL, Langstrom B, Persson L, Enblad P: Haemodynamic and metabolic disturbances in the acute stage of subarachnoid haemorrhage demonstrated by PET. Acta Neurol Scand 109:25-32, 2004 (Pubitemid 38161123)
12. Gobbel GT, Cann CE, Iwamoto HS, Fike JR: Measurement of regional cerebral blood flow in the dog using ultrafast computed tomography. Experimental validation. Stroke 22:772-779, 1991
13. Grasso G, Buemi M, Alafaci C, Sfacteria A, Passalacqua M, Sturiale A, et al: Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage. Proc Natl Acad Sci U S A 99:5627-5631, 2002 (Pubitemid 34411600)
14. Hirakata H, Yao H, Osato S, Ibayashi S, Onoyama K, Otsuka M, et al: CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO. Am J Physiol 262:F737-F743, 1992
15. Hoeffner EG, Case I, Jain R, Gujar SK, Shah GV, Deveikis JP, et al: Cerebral perfusion CT: technique and clinical applications. Radiology 231:632-644, 2004 (Pubitemid 38668077)
16. Keyrouz SG, Diringer MN: Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 11:220, 2007
17. Klingelhofer J, Dander D, Holzgraefe M, Bischoff C, Conrad B: Cerebral vasospasm evaluated by transcranial doppler ultrasonography at different intracranial pressures. J Neurosurg 75:752-758, 1991
18. Kudo K, Terae S, Katoh C, Oka M, Shiga T, Tamaki N, et al: Quantitative cerebral blood flow measurement with dynamic perfusion CT using the vascular-pixel elimination method: comparison with H2(15)O positron emission tomography. AJNR Am J Neuroradiol 24:419-426, 2003 (Pubitemid 36358995)
19. Laslo AM, Eastwood JD, Chen FX, Lee TY: Dynamic CT perfusion imaging in subarachnoid hemorrhage-related vasospasm. AJNR Am J Neuroradiol 27:624-631, 2006
20. Lee TY: Functional CT: physiological models. Trends Biotechnol 20:S3-S10, 2002
21. Leist M, Ghezzi P, Grasso G, Bianchi R, Villa P, Fratelli M, et al: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305:239-242, 2004 (Pubitemid 38886736)
22. Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, et al: Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 31:383-391, 2000 (Pubitemid 30078170)
23. Malhotra S, Nijhawan S, Rosenbaum DM: Erythropoietin (epoetin) as a protective factor for the brain. Curr Atheroscler Rep 6:301-306, 2004 (Pubitemid 39359470)
24. Mayberg MR: Cerebral vasospasm. Neurosurg Clin N Am 9:615-627, 1998
25. Metry G, Wikstrom B, Valind S, Sandhagen B, Linde T, Beshara S, et al: Effect of normalization of hematocrit on brain circulation and metabolism in hemodialysis patients. J Am Soc Nephrol 10:854-863, 1999 (Pubitemid 29149537)
26. Morishita E, Masuda S, Nagao M, Yasuda Y, Sasaki R: Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vi tro glutamate-induced neuronal death. Neuroscience 76:105-116, 1997 (Pubitemid 26407940)
27. Murai Y, Kominami S, Kobayashi S, Mizunari T, Teramoto A: The long-term effects of transluminal balloon angioplasty for vasospasms after subarachnoid hemorrhage: analyses of cerebral blood flow and reactivity. Surg Neurol 64:122-127, 2005 (Pubitemid 41044132)
28. Nabavi DG, Cenic A, Craen RA, Gelb AW, Bennett JD, Kozak R, et al: CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 213:141-149, 1999 (Pubitemid 29470420)
29. Nabavi DG, Cenic A, Dool J, Smith RM, Espinosa F, Craen RA, et al: Quantitative assessment of cerebral hemodynamics using CT: stability, accuracy, and precision studies in dogs. J Comput Assist Tomogr 23:506-515, 1999 (Pubitemid 29337139)
30. Nabavi DG, Cenic A, Henderson S, Gelb AW, Lee TY: Perfusion mapping using computed tomography allows accurate prediction of cerebral infarction in experimental brain ischemia. Stroke 32:175-183, 2001 (Pubitemid 32063843)
31. Nabavi DG, LeBlanc LM, Baxter B, Lee DH, Fox AJ, Lownie SP, et al: Monitoring cerebral perfusion after subarachnoid hemorrhage using CT. Neuroradiology 43:7-16, 2001 (Pubitemid 32123961)
32. Ohkuma H, Tsurutani H, Suzuki S: Changes of beta-actin mRNA expression in canine vasospastic basilar artery after experimental subarachnoid hemorrhage. Neurosci Lett 311:9-12, 2001 (Pubitemid 32831490)
33. Pluta RM: Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment. Pharmacol Ther 105:23-56, 2005
34. Santhanam AV, Smith LA, Akiyama M, Rosales AG, Bailey KR, Katusic ZS: Role of endothelial NO synthase phosphorylation in cerebrovascular protective effect of recombinant erythropoietin during subarachnoid hemorrhage-induced cerebral vasospasm. Stroke 36:2731-2737, 2005
35. Smith ML, Abrahams JM, Chandela S, Smith MJ, Hurst RW, Le Roux PD: Subarachnoid hemorrhage on computed tomography scanning and the development of cerebral vasospasm: the Fisher grade revisited. Surg Neurol 63:229-234, 2005 (Pubitemid 40278998)
36. Sobey CG, Faraci FM: Subarachnoid haemorrhage: what happens to the cerebral arteries? Clin Exp Pharmacol Physiol 25:867-876, 1998
37. Springborg JB, Ma X, Rochat P, Knudsen GM, Amtorp O, Paul son OB, et al: A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br J Pharmacol 135:823-829, 2002 (Pubitemid 34177660)
38. Strong MJ, Wolff AV, Wakayama I, Garruto RM: Aluminum-induced chronic myelopathy in rabbits. Neurotoxicology 12:9-21, 1991
39. Treggiari MM, Walder B, Suter PM, Romand JA: Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 98:978-984, 2003 (Pubitemid 36460888)
40. van Gijn J, Rinkel GJ: Subarachnoid haemorrhage: diagnosis, causes and management. Brain 124:249-278, 2001
41. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, et al: Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971-975, 2003 (Pubitemid 37152934)
42. Voldby B, Enevoldsen EM, Jensen FT: Cerebrovascular reactivity in patients with ruptured intracranial aneurysms. J Neu rosurg 62:59-67, 1985 (Pubitemid 15199404)
43. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M: Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 21:857-864, 2001 (Pubitemid 32613540)
44. Wijdicks EF, Kallmes DF, Manno EM, Fulgham JR, Piepgras DG: Subarachnoid hemorrhage: neurointensive care and aneurysm repair. Mayo Clin Proc 80:550-559, 2005
45. Wintermark M, Ko NU, Smith WS, Liu S, Higashida RT, Dillon WP: Vasospasm after subarachnoid hemorrhage: utility of perfusion CT and CT angiography on diagnosis and management. AJNR Am J Neuroradiol 27:26-34, 2006 (Pubitemid 46939879)
46. Xenocostas A, Cheung WK, Farrell F, Zakszewski C, Kelley M, Lutynski A, et al: The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietin. Eur J Clin Pharmacol 61:189-195, 2005 (Pubitemid 40768551)
47. Yamaji R, Okada T, Moriya M, Naito M, Tsuruo T, Miya take K, et al: Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem 239:494-500, 1996 (Pubitemid 26246558)
48. Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovitch AG, et al: Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J 19:1701-1703, 2005 (Pubitemid 41429535)
49. Yundt KD, Grubb RL Jr, Diringer MN, Powers WJ: Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab 18:419-424, 1998